Fig 1. 117 of 149 patients were positive for 1, 2, 3 or 4 serotypes of DENV as assessed by the PRNT50; patient serum was then further assessed for neutralizing capabilities at the PRNT80 level, often resulting in a lower order combination neutralization or no neutralization at all.